Literature DB >> 16890527

ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo.

Jeffrey B Wyckoff1, Sophie E Pinner, Steve Gschmeissner, John S Condeelis, Erik Sahai.   

Abstract

Tumor cells invading three-dimensional matrices need to remodel the extracellular matrix (ECM) in their path. Many studies have focused on the role of extracellular proteases; however, cells with amoeboid or rounded morphologies are able to invade even when these enzymes are inhibited. Here, we describe the mechanism by which cells move through a dense ECM without proteolysis. Amoeboid tumor cells generate sufficient actomyosin force to deform collagen fibers and are able to push through the ECM. Force generation is elevated in metastatic MTLn3E cells, and this correlates with increased invasion and altered myosin light chain (MLC) organization. In metastatic cells, MLC is organized perpendicularly to the direction of movement behind the invading edge. Both the organization of MLC and force generation are dependent upon ROCK function. We demonstrate that ROCK regulates the phosphorylation of MLC just behind the invading margin of the cell. Imaging of live tumors shows that MLC is organized in a similar ROCK-dependent fashion in vivo and that inhibition of ROCK but not matrix-metalloproteases reduces cancer cell motility in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890527     DOI: 10.1016/j.cub.2006.05.065

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  219 in total

1.  Visualizing extravasation dynamics of metastatic tumor cells.

Authors:  Konstantin Stoletov; Hisashi Kato; Erin Zardouzian; Jonathan Kelber; Jing Yang; Sanford Shattil; Richard Klemke
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

Review 2.  Microenvironmental control of the breast cancer cell cycle.

Authors:  Xun Guo; Yuehan Wu; Helen J Hathaway; Rebecca S Hartley
Journal:  Anat Rec (Hoboken)       Date:  2012-01-24       Impact factor: 2.064

3.  RAC1 activation mediates Twist1-induced cancer cell migration.

Authors:  Wen-Hao Yang; Hsin-Yi Lan; Chi-Hung Huang; Shyh-Kuan Tai; Cheng-Hwai Tzeng; Shou-Yen Kao; Kou-Juey Wu; Mien-Chie Hung; Muh-Hwa Yang
Journal:  Nat Cell Biol       Date:  2012-03-11       Impact factor: 28.824

Review 4.  The ROCK signaling and breast cancer metastasis.

Authors:  Sijin Liu
Journal:  Mol Biol Rep       Date:  2010-07-03       Impact factor: 2.316

Review 5.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

Authors:  Pepper Schedin; Patricia J Keely
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 6.  In vivo imaging in cancer.

Authors:  John Condeelis; Ralph Weissleder
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-22       Impact factor: 10.005

Review 7.  Single-Cell Migration in Complex Microenvironments: Mechanics and Signaling Dynamics.

Authors:  Michael Mak; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

8.  Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion.

Authors:  Thomas M Kitzing; Arul S Sahadevan; Dominique T Brandt; Helga Knieling; Sebastian Hannemann; Oliver T Fackler; Jörg Grosshans; Robert Grosse
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

9.  Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model.

Authors:  Shawn P Carey; Alina Starchenko; Alexandra L McGregor; Cynthia A Reinhart-King
Journal:  Clin Exp Metastasis       Date:  2013-01-18       Impact factor: 5.150

Review 10.  Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover.

Authors:  Neil O Carragher
Journal:  Clin Exp Metastasis       Date:  2008-10-29       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.